APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Valsartan Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchValsartan Tablets Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Tablets Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Valsartan Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Valsartan Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan Tablets include Alembic, Aurobindo, Cadista, Camber, Lupin, Major, Repackagers, Solco Healthcare and Changzhou Siyao Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan Tablets Segment by Company

Alembic

Aurobindo

Cadista

Camber

Lupin

Major

Repackagers

Solco Healthcare

Changzhou Siyao Pharmaceutical

Mylan

Teva

Zhejiang Huahai Pharm

Valsartan Tablets Segment by Type

80mg

40mg

320mg

160mg

Valsartan Tablets Segment by Application

Clinic

Hospital

Recovery Center

Valsartan Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Valsartan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Valsartan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Valsartan Tablets Industry Trends Table 2. Valsartan Tablets Industry Drivers Table 3. Valsartan Tablets Industry Opportunities and Challenges Table 4. Valsartan Tablets Industry Restraints Table 5. Global Valsartan Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Valsartan Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Valsartan Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Valsartan Tablets Sales Market Share by Manufacturers Table 9. Global Valsartan Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Valsartan Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Valsartan Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Valsartan Tablets Manufacturers, Product Type & Application Table 13. Global Valsartan Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 80mg Table 17. Major Manufacturers of 40mg Table 18. Major Manufacturers of 320mg Table 19. Major Manufacturers of 160mg Table 20. Global Valsartan Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Valsartan Tablets Sales by Type (2021-2026) & (K Units) Table 22. Global Valsartan Tablets Sales by Type (2027-2032) & (K Units) Table 23. Global Valsartan Tablets Sales Market Share by Type (2021-2026) Table 24. Global Valsartan Tablets Sales Market Share by Type (2027-2032) Table 25. Global Valsartan Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Valsartan Tablets Revenue by Type (2021-2026) & (K Units) Table 27. Global Valsartan Tablets Revenue by Type (2027-2032) & (K Units) Table 28. Global Valsartan Tablets Revenue Market Share by Type (2021-2026) Table 29. Global Valsartan Tablets Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Recovery Center Table 33. Global Valsartan Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Valsartan Tablets Sales by Application (2021-2026) & (K Units) Table 35. Global Valsartan Tablets Sales by Application (2027-2032) & (K Units) Table 36. Global Valsartan Tablets Sales Market Share by Application (2021-2026) Table 37. Global Valsartan Tablets Sales Market Share by Application (2027-2032) Table 38. Global Valsartan Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Valsartan Tablets Revenue by Application (2021-2026) & (K Units) Table 40. Global Valsartan Tablets Revenue by Application (2027-2032) & (K Units) Table 41. Global Valsartan Tablets Revenue Market Share by Application (2021-2026) Table 42. Global Valsartan Tablets Revenue Market Share by Application (2027-2032) Table 43. Global Valsartan Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Valsartan Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Valsartan Tablets Sales Market Share by Region (2021-2026) Table 46. Global Valsartan Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Valsartan Tablets Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Valsartan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 50. North America Valsartan Tablets Sales by Country (2027-2032) & (K Units) Table 51. Europe Valsartan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 53. Europe Valsartan Tablets Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Valsartan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Valsartan Tablets Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Valsartan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Valsartan Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Valsartan Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Valsartan Tablets Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Valsartan Tablets Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Valsartan Tablets Revenue Market Share by Region (2021-2026) Table 64. Global Valsartan Tablets Revenue Market Share by Region (2027-2032) Table 65. Alembic Company Information Table 66. Alembic Business Overview Table 67. Alembic Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Alembic Valsartan Tablets Product Portfolio Table 69. Alembic Recent Development Table 70. Aurobindo Company Information Table 71. Aurobindo Business Overview Table 72. Aurobindo Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Aurobindo Valsartan Tablets Product Portfolio Table 74. Aurobindo Recent Development Table 75. Cadista Company Information Table 76. Cadista Business Overview Table 77. Cadista Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Cadista Valsartan Tablets Product Portfolio Table 79. Cadista Recent Development Table 80. Camber Company Information Table 81. Camber Business Overview Table 82. Camber Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Camber Valsartan Tablets Product Portfolio Table 84. Camber Recent Development Table 85. Lupin Company Information Table 86. Lupin Business Overview Table 87. Lupin Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Lupin Valsartan Tablets Product Portfolio Table 89. Lupin Recent Development Table 90. Major Company Information Table 91. Major Business Overview Table 92. Major Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Major Valsartan Tablets Product Portfolio Table 94. Major Recent Development Table 95. Repackagers Company Information Table 96. Repackagers Business Overview Table 97. Repackagers Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Repackagers Valsartan Tablets Product Portfolio Table 99. Repackagers Recent Development Table 100. Solco Healthcare Company Information Table 101. Solco Healthcare Business Overview Table 102. Solco Healthcare Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Solco Healthcare Valsartan Tablets Product Portfolio Table 104. Solco Healthcare Recent Development Table 105. Changzhou Siyao Pharmaceutical Company Information Table 106. Changzhou Siyao Pharmaceutical Business Overview Table 107. Changzhou Siyao Pharmaceutical Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio Table 109. Changzhou Siyao Pharmaceutical Recent Development Table 110. Mylan Company Information Table 111. Mylan Business Overview Table 112. Mylan Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Mylan Valsartan Tablets Product Portfolio Table 114. Mylan Recent Development Table 115. Teva Company Information Table 116. Teva Business Overview Table 117. Teva Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Teva Valsartan Tablets Product Portfolio Table 119. Teva Recent Development Table 120. Zhejiang Huahai Pharm Company Information Table 121. Zhejiang Huahai Pharm Business Overview Table 122. Zhejiang Huahai Pharm Valsartan Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio Table 124. Zhejiang Huahai Pharm Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Valsartan Tablets Distributors List Table 128. Valsartan Tablets Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Valsartan Tablets Product Image Figure 2. Global Valsartan Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan Tablets Sales (2021-2032) & (K Units) Figure 5. Global Valsartan Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Valsartan Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 80mg Image Figure 9. 40mg Image Figure 10. 320mg Image Figure 11. 160mg Image Figure 12. Global Valsartan Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Valsartan Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Valsartan Tablets Sales Market Share by Type (2021-2032) Figure 15. Global Valsartan Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Valsartan Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Valsartan Tablets Revenue Market Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Recovery Center Image Figure 21. Global Valsartan Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Valsartan Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Valsartan Tablets Sales Market Share by Application (2021-2032) Figure 24. Global Valsartan Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Valsartan Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Valsartan Tablets Revenue Market Share by Application (2021-2032) Figure 27. North America Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Valsartan Tablets Sales Market Share by Country (2021-2032) Figure 29. U.S. Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Valsartan Tablets Sales Market Share by Country (2021-2032) Figure 34. Germany Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Valsartan Tablets Sales Market Share by Country (2021-2032) Figure 41. China Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Valsartan Tablets Sales Market Share by Country (2021-2032) Figure 49. Brazil Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Valsartan Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Valsartan Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Valsartan Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Valsartan Tablets Revenue (2021-2032) & (US$ Million) Figure 60. North America Valsartan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Valsartan Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Europe Valsartan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Valsartan Tablets Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Valsartan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Valsartan Tablets Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Valsartan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Valsartan Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Valsartan Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg
  • 40mg
  • 320mg
  • 160mg
Applications
  • Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Alembic
  • Aurobindo
  • Cadista
  • Camber
  • Lupin
  • Major
  • Repackagers
  • Solco Healthcare
  • Changzhou Siyao Pharmaceutical
  • Mylan
  • Teva
  • Zhejiang Huahai Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Valsartan Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Valsartan Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Valsartan Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Valsartan Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Valsartan Tablets Market Dynamics
  1. 2.1 Valsartan Tablets Industry Trends
  2. 2.2 Valsartan Tablets Industry Drivers
  3. 2.3 Valsartan Tablets Industry Opportunities and Challenges
  4. 2.4 Valsartan Tablets Industry Restraints
3 Valsartan Tablets Market by Manufacturers
  1. 3.1 Global Valsartan Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Valsartan Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Valsartan Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Valsartan Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Valsartan Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Valsartan Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan Tablets Tier 1, Tier 2, and Tier 3
4 Valsartan Tablets Market by Type
  1. 4.1 Valsartan Tablets Type Introduction
  2. 4.1.1 80mg
  3. 4.1.2 40mg
  4. 4.1.3 320mg
  5. 4.1.4 160mg
  6. 4.2 Global Valsartan Tablets Sales by Type
  7. 4.2.1 Global Valsartan Tablets Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Valsartan Tablets Sales by Type (2021-2032)
  9. 4.2.3 Global Valsartan Tablets Sales Market Share by Type (2021-2032)
  10. 4.3 Global Valsartan Tablets Revenue by Type
  11. 4.3.1 Global Valsartan Tablets Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Valsartan Tablets Revenue by Type (2021-2032)
  13. 4.3.3 Global Valsartan Tablets Revenue Market Share by Type (2021-2032)
5 Valsartan Tablets Market by Application
  1. 5.1 Valsartan Tablets Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Valsartan Tablets Sales by Application
  6. 5.2.1 Global Valsartan Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Valsartan Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Valsartan Tablets Revenue by Application
  10. 5.3.1 Global Valsartan Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Valsartan Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Valsartan Tablets Revenue Market Share by Application (2021-2032)
6 Global Valsartan Tablets Sales by Region
  1. 6.1 Global Valsartan Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Valsartan Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Valsartan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Valsartan Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Valsartan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Valsartan Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Valsartan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Valsartan Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Valsartan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Valsartan Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Valsartan Tablets Revenue by Region
  1. 7.1 Global Valsartan Tablets Revenue by Region
  2. 7.1.1 Global Valsartan Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Valsartan Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Valsartan Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Valsartan Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Valsartan Tablets Revenue (2021-2032)
  8. 7.2.2 North America Valsartan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Valsartan Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Valsartan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Valsartan Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Valsartan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Valsartan Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Valsartan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic
  2. 8.1.1 Alembic Company Information
  3. 8.1.2 Alembic Business Overview
  4. 8.1.3 Alembic Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Valsartan Tablets Product Portfolio
  6. 8.1.5 Alembic Recent Developments
  7. 8.2 Aurobindo
  8. 8.2.1 Aurobindo Company Information
  9. 8.2.2 Aurobindo Business Overview
  10. 8.2.3 Aurobindo Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aurobindo Valsartan Tablets Product Portfolio
  12. 8.2.5 Aurobindo Recent Developments
  13. 8.3 Cadista
  14. 8.3.1 Cadista Company Information
  15. 8.3.2 Cadista Business Overview
  16. 8.3.3 Cadista Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cadista Valsartan Tablets Product Portfolio
  18. 8.3.5 Cadista Recent Developments
  19. 8.4 Camber
  20. 8.4.1 Camber Company Information
  21. 8.4.2 Camber Business Overview
  22. 8.4.3 Camber Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Camber Valsartan Tablets Product Portfolio
  24. 8.4.5 Camber Recent Developments
  25. 8.5 Lupin
  26. 8.5.1 Lupin Company Information
  27. 8.5.2 Lupin Business Overview
  28. 8.5.3 Lupin Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lupin Valsartan Tablets Product Portfolio
  30. 8.5.5 Lupin Recent Developments
  31. 8.6 Major
  32. 8.6.1 Major Company Information
  33. 8.6.2 Major Business Overview
  34. 8.6.3 Major Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Major Valsartan Tablets Product Portfolio
  36. 8.6.5 Major Recent Developments
  37. 8.7 Repackagers
  38. 8.7.1 Repackagers Company Information
  39. 8.7.2 Repackagers Business Overview
  40. 8.7.3 Repackagers Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Repackagers Valsartan Tablets Product Portfolio
  42. 8.7.5 Repackagers Recent Developments
  43. 8.8 Solco Healthcare
  44. 8.8.1 Solco Healthcare Company Information
  45. 8.8.2 Solco Healthcare Business Overview
  46. 8.8.3 Solco Healthcare Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Solco Healthcare Valsartan Tablets Product Portfolio
  48. 8.8.5 Solco Healthcare Recent Developments
  49. 8.9 Changzhou Siyao Pharmaceutical
  50. 8.9.1 Changzhou Siyao Pharmaceutical Company Information
  51. 8.9.2 Changzhou Siyao Pharmaceutical Business Overview
  52. 8.9.3 Changzhou Siyao Pharmaceutical Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio
  54. 8.9.5 Changzhou Siyao Pharmaceutical Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Valsartan Tablets Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Teva Valsartan Tablets Product Portfolio
  66. 8.11.5 Teva Recent Developments
  67. 8.12 Zhejiang Huahai Pharm
  68. 8.12.1 Zhejiang Huahai Pharm Company Information
  69. 8.12.2 Zhejiang Huahai Pharm Business Overview
  70. 8.12.3 Zhejiang Huahai Pharm Valsartan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio
  72. 8.12.5 Zhejiang Huahai Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan Tablets Value Chain Analysis
  2. 9.1.1 Valsartan Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan Tablets Production Mode & Process
  6. 9.2 Valsartan Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan Tablets Distributors
  9. 9.2.3 Valsartan Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst